Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

AGA patients have higher heart disease risk.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Serenoa repens (saw palmetto) may cause side effects like hot flashes in children and needs more research for safety in pediatric use.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Spironolactone may help reduce hair loss in androgenic alopecia.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

PCOS often causes acne, dark skin patches, excess hair, and hair loss, linked to hormone levels and obesity.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.